loading
Precedente Chiudi:
$4.20
Aprire:
$4.23
Volume 24 ore:
639.69K
Relative Volume:
0.43
Capitalizzazione di mercato:
$412.21M
Reddito:
$58.36M
Utile/perdita netta:
$-25.72M
Rapporto P/E:
-11.40
EPS:
-0.3641
Flusso di cassa netto:
$-24.91M
1 W Prestazione:
-1.19%
1M Prestazione:
+27.69%
6M Prestazione:
+34.30%
1 anno Prestazione:
+20.29%
Intervallo 1D:
Value
$4.09
$4.23
Intervallo di 1 settimana:
Value
$3.955
$4.3693
Portata 52W:
Value
$2.12
$5.80

Aquestive Therapeutics Inc Stock (AQST) Company Profile

Name
Nome
Aquestive Therapeutics Inc
Name
Telefono
908-941-1900
Name
Indirizzo
30 TECHNOLOGY DRIVE, WARREN, NJ
Name
Dipendente
142
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-05
Name
Ultimi documenti SEC
Name
AQST's Discussions on Twitter

Confronta AQST con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
AQST
Aquestive Therapeutics Inc
4.15 417.18M 58.36M -25.72M -24.91M -0.3641
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
152.12 68.04B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.48 46.30B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.88 44.25B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.54 18.73B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
304.50 13.82B 2.99B 1.21B 1.13B 25.06

Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-02 Ripresa Oppenheimer Outperform
2024-12-17 Iniziato Cantor Fitzgerald Overweight
2024-05-10 Iniziato Leerink Partners Outperform
2024-04-11 Iniziato Piper Sandler Overweight
2024-03-28 Iniziato Raymond James Outperform
2021-04-07 Ripresa RBC Capital Mkts Outperform
2019-04-22 Iniziato H.C. Wainwright Buy
2019-01-03 Iniziato Lake Street Buy
2018-08-20 Iniziato JMP Securities Mkt Outperform
2018-08-20 Iniziato RBC Capital Mkts Outperform
Mostra tutto

Aquestive Therapeutics Inc Borsa (AQST) Ultime notizie

pulisher
Jul 25, 2025

Is Aquestive Therapeutics Inc. a good long term investmentExceptional stock performance - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Why Aquestive Therapeutics Inc. stock is on top investor watchlistsFree Bull & Bear Market Updates - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Should I buy Aquestive Therapeutics Inc. stock before earningsRapidly growing investment returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Aquestive Therapeutics Inc. Stock Analysis and ForecastBreakthrough investment results - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Aquestive Therapeutics Inc. stock outlookRobust financial gains - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Aquestive Therapeutics Inc. stock priceFree Capital Allocation Plans - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Aquestive Therapeutics Inc. stockAccelerated profit realization - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

EpiPen Veteran to Lead Aquestive's Revolutionary Oral Epinephrine Launch as New Chief Commercial Officer - Stock Titan

Jul 22, 2025
pulisher
Jul 21, 2025

After Leaping 29% Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Are Not Flying Under The Radar - simplywall.st

Jul 21, 2025
pulisher
Jul 21, 2025

Aquestive's Anaphylm to be reviewed by Health Canada - MSN

Jul 21, 2025
pulisher
Jul 18, 2025

When is the best time to buy Aquestive Therapeutics Inc. stockAlpha Stock Ideas - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Will Aquestive Therapeutics Inc. stock benefit from AI tech trendsFree Professional Portfolio Management - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Why Aquestive Therapeutics Inc. stock attracts strong analyst attentionSteady Income Ideas - beatles.ru

Jul 17, 2025
pulisher
Jul 16, 2025

Cantor Equity Partners I, Inc. shares rise 2.24% premarket after Aquestive Therapeutics' positive drug submission meeting with Health Canada. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

11,303 Shares in Aquestive Therapeutics, Inc. (NASDAQ:AQST) Acquired by Cambridge Investment Research Advisors Inc. - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film - GlobeNewswire

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Aquestive Therapeutics Inc. stock price move sharplyFree High-Profit Stock Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Aquestive's Anaphylm to be reviewed by Health Canada (AQST) - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Aquestive schedules regulatory meetings for epinephrine film in Canada, EU - Investing.com Canada

Jul 15, 2025
pulisher
Jul 15, 2025

How Aquestive Therapeutics Inc. stock performs during market volatilityDaily Stock Radar - Newser

Jul 15, 2025

Aquestive Therapeutics Inc Azioni (AQST) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$72.93
price up icon 2.82%
$14.92
price up icon 1.57%
$9.41
price up icon 0.64%
drug_manufacturers_specialty_generic RDY
$14.67
price down icon 0.27%
$132.14
price up icon 0.38%
$304.50
price down icon 0.62%
Capitalizzazione:     |  Volume (24 ore):